Deferasirox (Austhera Biosciences)

地拉罗司 (Austhera Biosciences)

Report date: 2025/06/05 20:00:13

Base Information

Drug NameDeferasirox (Austhera Biosciences)
Drug Alias NameAST-0509K-DFXDST-0509
ClassificationSmall molecules > Polymers and chelators
Mechanisms of ActionIron chelating agents
TargetsNot applicable
Therapy Area/Indicationsbeta-Thalassemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesThailand
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDispersol Technologies Llc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active Indicationsbeta-Thalassemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A